Notice: Images are for illustration only and may not reflect the exact product you receive. Brand-name medications may look different depending on their country of origin—Canadian versions, for example, often include a "PR" symbol on the packaging. Rest assured, the medication, dosage, and active ingredients will be exactly as prescribed. Canada Pharmacy Store is committed to your health and safety, and we work only with licensed pharmacies to ensure you receive trusted, high-quality medication every time.
General Medication Fact Sheet for Rymti
| Field | Information |
|---|---|
| Medication Name | Rymti |
| Generic Name | Tildrakizumab |
| Purpose | Treatment of moderate-to-severe plaque psoriasis in adults |
| Mechanism of Action | Selective interleukin-23 (IL-23) inhibitor |
| Dosage Forms | Subcutaneous injection |
| Available Strengths | 100 mg/mL |
| Dosage Frequency | Administered by subcutaneous injection at weeks 0 and 4, then every 12 weeks thereafter |
| Common Side Effects | Upper respiratory infections, injection site reactions, diarrhea |
| Serious Side Effects | Serious allergic reactions, infections |
| Drug Interactions | Live vaccines, immunosuppressants |
| Important Notes | Consult a healthcare provider before starting Rymti if you have a history of serious infections; avoid live vaccines during treatment. |
| Storage | Store refrigerated at 2-8°C (36-46°F) in the original carton to protect from light |
| Missed Dose | Contact your healthcare provider for instructions |
| Alternatives | Skyrizi (risankizumab), Tremfya (guselkumab), Cosentyx (secukinumab) |
Rymti Alternatives
| Medication | Mechanism of Action | Notes |
|---|---|---|
| Skyrizi (risankizumab) | IL-23 inhibitor | Similar mechanism to Rymti, another biologic for psoriasis. |
| Tremfya (guselkumab) | IL-23 inhibitor | Also targets IL-23, used for treating plaque psoriasis. |
| Cosentyx (secukinumab) | IL-17A inhibitor | Different mechanism, targets IL-17A, another cytokine involved in psoriasis. |
| Humira (adalimumab) | TNF-alpha inhibitor | Targets TNF-alpha, another treatment option for psoriasis. |
Rymti Side Effects
| Common Side Effects | Serious Side Effects |
|---|---|
| Upper respiratory infections (e.g., common cold) | Serious allergic reactions (anaphylaxis, angioedema) |
| Injection site reactions (pain, redness, swelling) | Infections (bacterial, viral, fungal) |
| Diarrhea | Worsening of Crohn’s disease or ulcerative colitis |
| Headache | Increased risk of certain cancers (rare) |
Rymti Dosage Guide
| Condition | Starting Dose | Maintenance Dose | Administration Notes |
|---|---|---|---|
| Plaque Psoriasis | 100 mg | 100 mg every 12 weeks | Administered by subcutaneous injection at weeks 0 and 4, then every 12 weeks thereafter. |
Rymti Price With And Without Insurance
| Purchase Context | Estimated Price |
|---|---|
| With Insurance | $300 |
| Without Insurance (U.S.) | $7,050 |
| From CPS | $1,488 |
